Cargando…
Sphingosine kinase 2 and multiple myeloma
Autores principales: | Pyne, Nigel J., Pyne, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546425/ https://www.ncbi.nlm.nih.gov/pubmed/28455955 http://dx.doi.org/10.18632/oncotarget.17420 |
Ejemplares similares
-
Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers
por: Pyne, Susan, et al.
Publicado: (2012) -
Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells
por: Pyne, Nigel J., et al.
Publicado: (2017) -
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells
por: McNaughton, Melissa, et al.
Publicado: (2016) -
Selectivity and Specificity of Sphingosine 1-Phosphate Receptor Ligands: “Off-Targets” or Complex Pharmacology?
por: Pyne, Nigel J., et al.
Publicado: (2011) -
Structure–Activity
Relationships and Molecular
Modeling of Sphingosine Kinase Inhibitors
por: Baek, Dong Jae, et al.
Publicado: (2013)